Clinical trial
A Prospective Multi-Center Clinical Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RxLAL) With the Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism
NCT03771352 is registered in ClinicalTrials.gov with RxSight, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multi-Center Clinical Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RxLAL) With the Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism
- Lead sponsor
- RxSight, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 19, 2018
- Completion date
- July 1, 2020
- Enrollment
- 55 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.